Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMS for Prevention of Transplant-Associated Lung Disease
NCT01432080Phase 2Terminated
- Sponsor
- Hôpital Maisonneuve-Rosemont
- Start
- Sep 2011
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of prednisone, azithromycin, montelukast, budesonide in Bronchiolitis Obliterans (BO), cryptogenic organizing pneumonia (COP), interstitial lung disease (ILD), sponsored by Hôpital Maisonneuve-Rosemont. Started Sep 2011; status: terminated.
02
Drugs
prednisoneazithromycinmontelukastbudesonide
03
Conditions
Bronchiolitis Obliterans (BO)cryptogenic organizing pneumonia (COP)interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT01432080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01432080.